Parkinson's Disease Clinical Trials
Find clinical trials for Parkinson's Disease. Search for Parkinson's Disease clinical trials in different cities and states across the United States.
Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.
Sponsor:
University of Minnesota
Location:
Code:
NCT06692920
Conditions
Parkinson Disease
Eligibility Criteria
Sex: All
Age: 21 - 70+
Healthy Volunteers: Not accepted
Interventions
DBS stimulation
User-friendliness of a Portable Driving SimulatorUser-friendliness of a Portable Driving Simulator
Sponsor:
University of Kansas Medical Center
Location:
Code:
NCT03969927
Conditions
Parkinson Disease
Multiple Sclerosis
Stroke
Eligibility Criteria
Sex: All
Age: 25 - 70+
Healthy Volunteers: Not accepted
Interventions
Low-Fidelity PDS
High Fidelity Fixed-Base Simulator
Phase 2a Study of VTX3232 in Parkinson's DiseasePhase 2a Study of VTX3232 in Parkinson's Disease
Sponsor:
Zomagen Biosciences Ltd.
Location:
Code:
NCT06556173
Conditions
Idiopathic Parkinson Disease
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
VTX3232
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Sponsor:
Intec Pharma Ltd.
Location:
Code:
NCT02615873
Conditions
Parkinson's Disease
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
Accordion Pill™ Carbidopa/Levodopa
Transcranial Direct Current Stimulation for Motor Function and Fatigue in PDTranscranial Direct Current Stimulation for Motor Function and Fatigue in PD
Sponsor:
Sanford Health
Location:
Code:
NCT06883266
Conditions
Parkinsons Disease (PD)
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
transcranial direct current stimulation (tDCS)
Sham (No Treatment)
Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's DiseasePilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease
Sponsor:
Oregon Health and Science University
Location:
Code:
NCT06772220
Conditions
Parkinson&Amp;#39;s Disease
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
Folic Acid 1 MG
Vitamin B6 25 MG
Vitamin B12
Apraxia in Parkinson's Disease Patients With Deep Brain StimulationApraxia in Parkinson's Disease Patients With Deep Brain Stimulation
Sponsor:
University of Florida
Location:
Code:
NCT04725773
Conditions
Deep Brain Stimulation
Parkinson Disease
Apraxia, Motor
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Deep brain stimulation effect on apraxia
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's DiseaseA Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
Sponsor:
InSightec
Location:
Code:
NCT04991831
Conditions
Tremor Associated With Tremor Dominant Parkinson's Disease
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
Unilateral thalamotomy
What are Parkinson's disease clinical trials?
Clinical trials for Parkinson’s disease are research studies conducted to evaluate the safety and effectiveness of new treatments for Parkinson's disease. These trials test new drugs, surgical procedures, or therapies to determine whether they offer benefits over existing treatments. The goal is to find more effective ways to manage the symptoms, slow down the progression, or potentially cure this disease.
How clinical trials contribute to treatments for Parkinson's disease
Clinical trials play a crucial role in developing new treatments for Parkinson's disease. They allow researchers to test the efficacy and safety of innovative therapies, medications, and interventions in controlled environments. Data gathered from these trials help in identifying treatments that can improve the quality of life for those living with Parkinson’s disease, offering hope for more effective management of the disease's symptoms and progression.
Types of treatments studied in Parkinson's disease clinical trials
Parkinson's disease clinical trials explore a wide range of treatments aimed at improving the lives of those affected by the condition. These treatments fall under 3 key types of studies:
New medications
Many clinical trials for Parkinson's disease focus on testing new medications designed to improve symptoms, slow disease progression, or manage side effects more effectively. These trials may explore different drugs to determine their effectiveness, optimal dosages, and combinations to find the most beneficial treatments.
Surgical interventions and devices
Some clinical trials examine the efficacy of surgical interventions, such as deep brain stimulation (DBS), or the use of medical devices that can alleviate symptoms or improve motor function in patients with Parkinson's disease. These studies aim to refine surgical techniques and develop innovative devices to enhance treatment outcomes.
Non-pharmacological therapies
Parkinson’s disease research also extends to non-pharmacological therapies, such as physical therapy, exercise, dietary changes, and cognitive-behavioral therapy. These trials investigate how lifestyle modifications and alternative therapies can contribute to managing Parkinson's disease symptoms and improving overall well-being.
Who can participate in Parkinson's disease research studies?
Eligibility for Parkinson's disease trials varies depending on the study's specific requirements. Generally, individuals diagnosed with Parkinson's disease at various stages of the disease may qualify. Criteria might include age, disease severity, medication history, and overall health status. Some trials might also be open to individuals without Parkinson's for preventive studies or to compare health outcomes.
What to expect when participating in a Parkinson's disease clinical trial
Participants can expect to undergo a thorough screening process to determine eligibility, followed by detailed information about the study's purpose, procedures, potential risks, and benefits. During the trial, participants might receive specific interventions and be closely monitored through regular health assessments and follow-ups to evaluate the treatment's effectiveness and any side effects.
Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
How to enroll in a clinical trial for Parkinson's disease
Enrolling in a clinical trial for Parkinson’s disease through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.